Candida infection of cerebrospinal fluid shunt devices: Report of two cases and review of the literature

Acta Neurochirurgica

Volumn 142, Issue 1, 2000, Pages 67-74

  Montero, A ^a   Romero, J ^a   Vargas, J A ^a   Regueiro, C A ^a   Sanchez Aloz G ^a   De Prados, F ^a   De La Torre, A ^a   Aragon G ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Candida; Clinical management.; CSF shunt; Meningitis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; RIFAMPICIN; STEROID; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL MENINGITIS; CANDIDIASIS; CASE REPORT; CEREBROSPINAL FLUID; FEMALE; HUMAN; INDWELLING CATHETER; INTRAVENOUS CATHETER; MALE; PRIORITY JOURNAL; SHUNT INFECTION; URINE CATHETER;

EID: 0033959269     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050009     Document Type: Article

References (41)

1. 1. Abter EIM, Lutwick LI, Torrey MJ, Mann R (1993) Cellulitis associated with bacteriemia due to Flavobacterium meningosepticum. Clin Infect Dis 17: 929-930
2. 2. Baehner RL, Neiburger RS, Johnson DG et al (1973) Transient bactericidal defects of peripheral blood phagocytes from children with acute lymphoblastic leukemia receiving craniospinal irradiation. N Engl J Med 289: 1209-1213
3. 3. Bayer A, Edwards J, Seidel J, Guze L (1976) Candida meningitis. Report of seven cases and review of the English literature. Medicine 55: 477-486
4. 4. Byers M, Chapman S, Feldman S et al (1992) Fluconazole pharmacokinetics in the cerebrospinal fluid of a chikd with Candida tropicalis meningitis. Peditr Infect Dis 11: 895-896
5. 5. Chesney PJ, Teets KC, Mulvihill JJ, Salit FE, Mark MI (1976) Successful treatment of Candida meningitis with amphotericine B and 5 fluorocytosine in combination. J Pediatr 89: 1017-1019
6. 6. Chiou C-C, WongT-T, Lin H-H et al (1994) Fungal infection of ventriculoperitoneal shunts in children. Clin Infect Dis 19: 1049-1053
7. 7. Cruciani M, Di Perri G, Molesini M et al (1992) Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infection. Eur J Clin Microbiol Infect Dis 11: 957
8. 8. Curry CR. Quie PG (1971) Fungal septicemia in patients receiving hyperalimentation. N Engl J Med 285: 1221-1225
9. 9. Forward KR, Fewer HD, Stirer HG (1983) Cerebrospinal fluid shunt infections: a review of 35 infections in 32 patients. J Neurosurg 54: 257-260
10. 10. Gardner P, Leipzig TJ, Sadigh M (1988) Infections of mechanical cerebrospinal fluid shunts. Current clinical topics in infectious diseases. JS Remington, MN Swartz (eds) McGraw-Hill, New York, pp 185-214
11. 11. George R, Liebrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections: a 25 year experience. J Neurosurg 51: 804-811
12. 12. Gower DJ, Crone K, Alexander E Jr, Kelly DL Jr (1986) Candida albicans shunt infection: report of two cases 19: 111-114
13. 13. Hiruma M, Nitta M, Kagawa S (1986) A case of cerebrospinal fluid shunt colonization and obstruction by Candida albicans. Mykosen 29: 455-460
14. 14. Holt R (1969) The classification of staphylococci from colonized ventriculo-atrial shunts. J Clin Pathol 22: 475-482
15. 15. McLaurin RL, Frame PT (1987) Treatment of infections of cerebrospinal fluid shunts. Clin Pharm 9: 595-603
16. 16. Mori T, Ebe T (1992) Analysis of cases of central nervous system fungal infections reported in Japan between January 1979 and June 1989. Intern Med 31: 174-9
17. 17. Nagata MP, Gentry CA, Hampton EM (1996). Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic Candida infections. Ann Pharmacother 30: 811-818
18. 18. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (1997) approved standard. NCCLS document M7-A4, 4 edn. National Committee for Clinical Laboratory Standards, Wayne Pennsylvania
19. 19. Nguyen MH, Yu V (1995) Meningitis caused by Candida species: an emerging problem in neurosurgical patients. Clin Infect Dis 21: 323-327
20. 20. O'Brien m, Parent A, Davis B (1979). Management of ventricular shunt infections. Childs Brain 5: 304-309
21. 21. Odio C, McCracken GH, Nelson JD (1984). CSF shunt infections in peditrics: a seven year experience. Am J Dis Child 138: 1103-1108
22. 22. Po-Ren H, Lee-Jene T, Shen-Wu H, Wei-Chuan H, Kwen-Tay L (1996) Clinical and microbiological characteristics of Flavobacterium indologens infections associated with indwelling devices. J Clin Micro 34: 1908-1913
23. 23. Po-Ren H, Tzuen-Ren H, Jiunn-Jong W et al (1996) Flavobacterium indologens bacteriemia: clinical and microbiological characteristics. Clin Infect Di 23: 550-555
24. 24. Prentice HG, Hann IM, Herbrecht R et al (1997) A randomized comparision of liposomal versus coventional amphotericine B for the treatment of pyrexia of unknown origin in neutropenic patients. Brit J Haemat 98: 711-718
25. 25. Raimondi AJ, Robinson JS, Kuwamura K (1977) Complications of ventriculo peritoneal shunting and critical comparision of the three -piece and one-piece systems. Childs Brain 3: 321-342
26. 26. Rekate HL, Ruch T, Nulsen FE (1978) Diphteroid infections of cerebrospinal fluid shunts: the changing pattern of shunt infections in Cleveland. J Neurosurg 52: 553-556
27. 27. Rodgers BM, Vries JK, Talbot JL (1978) Laparoscopy in the diagnosis of malfunctioning ventriculo-peritoneal shunts in children. J Pediatr Surg 13: 247-253
28. 28. Rosebury T (1962) Indigenous fungi. Microorganism indigenous to man. McGraw-Hill, New York, pp 237
29. 29. Sanchez-Portocarrero J, Martin-Rabadan P, Saldana CJ, Perez-Cecilia E (1994) Candida cerebrospinal fluid shunt infections. Report of two new cases and review of the literature. Diagn Microbiol Infect Dis 20: 33-40
30. 30. Schoenbaum SC, Gardner P, Shillito J (1975) Infections of cerebrospinal fluids shunts: epidemiology, clinical manifestations and therapy. J Infect Dis 131: 543-552
31. 31. Schwartz RS, McKintosh FR, Schrier SL, Greenberg PL (1984) Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 53: 411-419
32. 32. Shapiro S, Javed T, Mealey J (1989) Candida albicans shunt infection. Pediatr Neurosci 15: 125-130
33. 33. Sheridan RL, Ryan CM, Pasternack MS, Weber JM, Tompkins RG (1996) Flavobacterial sepsis in massively burned pediatric patients. Clin Infect Dis 17: 185-187
34. 34. Smith JA, Selik A, Edelist G (1973) A clinical and microbiologic study of venous catheterization. Can Med Assoc J 109: 115-117
35. 35. Sugarman B, Massanari M (1980) Candida meningitis in patients with cerebrospinal fluid shunt infections. Arch Neurol 37: 180-181
36. 36. Talbot GH, Provender M, Cassileth PA (1988) Persistent fever after recovery from granulocytopenia in acute leukemia. Arch Intern Med 148: 129-135
37. 37. Utz JP, Treger a, McCullough NB et al (1958) Amphotericin B: intravenous use in 21 patients with systemic fungal diseases. Antibiotics annual Medical Encyclopedia Inc, New York, pp 628-634
38. 38. Voice R, Bradley S, Sangcorzan J, Kauffman C (1994) Chronic candidal meningitis: an uncommun manifestation of candidiasis. Clin Infect Dis 19: 60-66
39. 39. Wade JC (1993) Epidemiology of Candida infections. In: Budey GP (ed) Candidiasis: pathogenesis, diagnosis and treatment, 2nd edn. Raven Press, New York, pp 85-107
40. 40. Walter EB, Gingran JL, McKinney RE (1990) Systemic Torulopsis glabrata infection in a neonate. South Med J 83: 837-838
41. 41. Yoguer R, Davis AT (1980) Neurosurgical shunt infections. Childs Brain 6: 74-81